Results
|
361.
|
|
|
362.
|
|
|
363.
|
|
|
364.
|
|
|
365.
|
|
|
366.
|
|
|
367.
|
|
|
368.
|
|
|
369.
|
|
|
370.
|
|
|
371.
|
|
|
372.
|
Lack of B7 expression, not human leukocyte antigen expression, facilitates immune evasion by human malignant gliomas. [electronic resource] by
- Anderson, Richard C E
- Anderson, David E
- Elder, James B
- Brown, Melandee D
- Mandigo, Christopher E
- Parsa, Andrew T
- Goodman, Robert R
- McKhann, Guy M
- Sisti, Michael B
- Bruce, Jeffrey N
Producer: 20070731
In:
Neurosurgery vol. 60
Availability: No items available.
|
|
373.
|
Serum-soluble B7x is elevated in renal cell carcinoma patients and is associated with advanced stage. [electronic resource] by
- Thompson, R Houston
- Zang, Xingxing
- Lohse, Christine M
- Leibovich, Bradley C
- Slovin, Susan F
- Reuter, Victor E
- Cheville, John C
- Blute, Michael L
- Russo, Paul
- Kwon, Eugene D
- Allison, James P
Producer: 20080908
In:
Cancer research vol. 68
Availability: No items available.
|
|
374.
|
|
|
375.
|
Inhibition of B7-1 (CD80) by RhuDex® reduces lipopolysaccharide-mediated inflammation in human atherosclerotic lesions. [electronic resource] by
- Doesch, Andreas O
- Zhao, Li
- Gleissner, Christian A
- Akhavanpoor, Mohammadreza
- Rohde, David
- Okuyucu, Deniz
- Hakimi, Maani
- Dengler, Thomas J
- Katus, Hugo A
- Erbel, Christian
Producer: 20141124
In:
Drug design, development and therapy vol. 8
Availability: No items available.
|
|
376.
|
|
|
377.
|
|
|
378.
|
T lymphocyte T cell-B cell-activating molecule/CD40-L molecules induce normal B cells or chronic lymphocytic leukemia B cells to express CD80 (B7/BB-1) and enhance their costimulatory activity. [electronic resource] by
- Yellin, M J
- Sinning, J
- Covey, L R
- Sherman, W
- Lee, J J
- Glickman-Nir, E
- Sippel, K C
- Rogers, J
- Cleary, A M
- Parker, M
Producer: 19940804
In:
Journal of immunology (Baltimore, Md. : 1950) vol. 153
Availability: No items available.
|
|
379.
|
|
|
380.
|
|